UCLA Fielding School of Public Health

Simple Cloth Masks Provide Significant Protection Against COVID-19 Transmission

UCLA Fielding School of Public Health research finds that even a simple cloth mask reduces the spread of COVID-19 respiratory droplets by 77 percent.

Newswise — LOS ANGELES (Nov. 11, 2020) - A study led by UCLA Fielding School of Public Health Professor Yifang Zhu has determined that even a simple cloth mask provides significant protections against COVID-19 transmission, reducing the spread of respiratory droplets by as much as 77%.

“We found that a simple cough could send particles more than six feet away, without face coverings,” said Zhu, professor in the Department of Environmental Health Sciences and associate dean for academic programs at the UCLA Fielding School of Public Health (UCLA FSPH). “At about a foot away from the coughing source, a face shield by itself provided the least protection (i.e., 4%). In contrast, a cloth mask reduced cough particles by 77%, and the combination of face shield and cloth mask improved the particle reduction to 89%.”

The article, “Assessing the effectiveness of using various face coverings to mitigate the transport of airborne particles produced by coughing indoors” is published in the current electronic edition of the peer-reviewed journal Aerosol Science and Technology.

Zhu’s team, which includes UCLA FSPH scholars Liqiao Li and Muchuan Niu, set up a test space in a lab and measured the particle number concentration (PNC) and particle size distribution under seven different conditions: (1) no face covering; (2) face shield only; (3) cloth mask; (4) face shield + cloth mask; (5) surgical mask; (6) face shield + surgical mask; (7) N95 respirator or equivalent (i.e., KN95 mask).

The research suggests that relatively simple measures like masking, combined with physical distancing, hand hygiene, and specific steps taken with regards to being indoors or outside, can make a significant difference in slowing the spread of COVID-19, which has resulted in more than 1.26 million deaths worldwide.

“To minimize the infection risk of aerosol transmission, stricter mitigation measures should be adopted for indoor environments, which are more likely to be enclosed and crowded,” Li said. “One of the simplest is a mask.”

Support: This work was supported in part by the University of California, Los Angeles.


The UCLA Fielding School of Public Health, founded in 1961, is dedicated to enhancing the public's health by conducting innovative research, training future leaders and health professionals from diverse backgrounds, translating research into policy and practice, and serving our local communities and the communities of the nation and the world. The school has 690 students from 25 nations engaged in carrying out the vision of building healthy futures in greater Los Angeles, California, the nation and the world.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 5429
Released: 16-Apr-2021 4:10 PM EDT
Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues
Rutgers University-New Brunswick

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

Released: 16-Apr-2021 3:15 PM EDT
Studies suggest people with blood cancers may not be optimally protected after COVID-19 vaccination
American Society of Hematology (ASH)

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.

Newswise: Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Released: 16-Apr-2021 2:35 PM EDT
Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Los Alamos National Laboratory

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

Newswise: 262279_web.jpg
Released: 16-Apr-2021 2:15 PM EDT
Experimental antiviral for COVID-19 effective in hamster study
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

Newswise:Video Embedded forum-tackles-vaccine-hesitancy-in-the-black-community
VIDEO
Released: 16-Apr-2021 1:25 PM EDT
Forum Tackles Vaccine Hesitancy in the Black Community
Cedars-Sinai

Leading healthcare and faith leaders addressed key issues that are contributing to vaccine hesitancy in Black communities during a national online discussion this week, explaining that a lack of access to healthcare, concerns over vaccine safety, and religious beliefs are keeping many from getting COVID-19 vaccines.

Newswise: COVID-19: Scientists identify human genes that fight infection
Released: 16-Apr-2021 1:10 PM EDT
COVID-19: Scientists identify human genes that fight infection
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters.

Newswise: Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Released: 16-Apr-2021 11:35 AM EDT
Study of More Than 3,000 Members of the US Marine Corps. Reveals Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection
Mount Sinai Health System

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.

Released: 15-Apr-2021 8:45 PM EDT
Beyond Boundaries: R Adams Cowley Shock Trauma Center Celebrates Heroes
University of Maryland Medical Center

More than 65 first responders and top trauma medicine professionals who saved the lives of two critically ill patients were honored tonight at the 31st annual R Adams Cowley Shock Trauma Celebration of Heroes. Funds raised by the virtual event will support the Center for Critical Care and Trauma Education.

Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.


Showing results

110 of 5429

close
1.08015